Asensus Surgical, Inc. (ASXC) |
|
0.55 0.01 (1.85%)
|
06-09 15:12 |
|
Open: |
0.54 |
Pre. Close: |
0.54 |
|
High:
|
0.575 |
Low:
|
0.54 |
|
Volume:
|
589,193 |
Market Cap:
|
132(M) |
|
|
|
Technical analysis |
as of: 2023-06-09 2:43:22 PM |
|
Short-term rate:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 0.71 One year: 0.8 |
| Support: |
Support1: 0.47 Support2: 0.39 |
| Resistance: |
Resistance1: 0.6 Resistance2: 0.68 |
| Pivot: |
0.54  |
| Moving Average: |
MA(5): 0.55 MA(20): 0.55
MA(100): 0.67 MA(250): 0.54 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 50.1 %D(3): 50.7 |
| RSI: |
RSI(14): 43.8 |
| 52-week: |
High: 1.17 Low: 0.28 |
| Average Vol(K): |
3-Month: 745 (K) 10-Days: 680 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ ASXC ] has closed below upper band by 43.8%. Bollinger Bands are 64.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.54 - 0.54 |
0.54 - 0.55 |
|
Low:
|
0.5 - 0.51 |
0.51 - 0.51 |
|
Close:
|
0.53 - 0.54 |
0.54 - 0.55 |
|
Company Description |
|
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures. Its products also comprise instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina. |
Headline News |
Thu, 01 Jun 2023
Asensus Shares First Quarter Results and Future Plans - Asensus Surgical (AMEX:ASXC) - Benzinga
Wed, 17 May 2023
Unusual Put Option Trade in Asensus Surgical (ASXC) Worth $7.50K - Nasdaq
Sat, 13 May 2023
HC Wainwright & Co. Reiterates Asensus Surgical (ASXC) Buy ... - Nasdaq
Fri, 12 May 2023
Earnings reports: Fathom Holdings, Asensus Surgical, VTv Therapeutics - WRAL TechWire
Thu, 11 May 2023
Asensus Surgical down 5% on Q1 misses (NYSE:ASXC) - Seeking Alpha
Thu, 11 May 2023
Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2023 - Yahoo Finance
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
0 (M) |
| Shares Float |
0 (M) |
|
% Held by Insiders
|
0 (%) |
|
% Held by Institutions
|
0 (%) |
|
Shares Short
|
0 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
0 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
0 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
0 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
